EcoDrugPlus

Protein Kinase C Beta

Ensembl ID : ENSOKIG00005043471
Gene Symbol: PRKCB
1 Cross references
206 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSOKIG00005040988
Gene Symbol: PRKCB
1 Cross references
212 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOKIG00005004713
Gene Symbol: PRKCD
3 Cross references
198 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOKIG00005018195
Gene Symbol: PRKCD
3 Cross references
197 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOKIG00005023828
Gene Symbol: PRKCD
3 Cross references
196 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSOKIG00005009824
Gene Symbol: LOC109891155
3 Cross references
198 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOKIG00005018068
Gene Symbol: PRKCE
1 Cross references
254 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOKIG00005047241
Gene Symbol: PRKCE
3 Cross references
250 Possible Orthologues:

Protein Kinase C Epsilon Type-Like

Ensembl ID : ENSOKIG00005031358
Gene Symbol: LOC109869986
2 Cross references
246 Possible Orthologues:

Protein Kinase C Eta Type

Ensembl ID : ENSOKIG00005023771
Gene Symbol: LOC109904112
3 Cross references
218 Possible Orthologues:

Protein Kinase C Iota Type

Ensembl ID : ENSOKIG00005045540
Gene Symbol: LOC109871756
3 Cross references
81 Possible Orthologues:

Protein Kinase C Iota Type-Like

Ensembl ID : ENSOKIG00005035033
Gene Symbol: LOC109874781
3 Cross references
80 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).